A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, according to new research ...
Jan 27, 2023
0
23
A University of Calgary research group joined forces with members of the World Health Organization (WHO) to tackle a global health question. What is the best protection against COVID-19? Analyzing data from controlled studies ...
Jan 20, 2023
0
51
High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection. These are the ...
Jan 16, 2023
0
37
A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate ...
Jan 6, 2023
1
83
Testing for procalcitonin, a blood biomarker that is increased in people with a bacterial infection, could help physicians more quickly and effectively determine whether patients need antibiotics. Knowing that would ultimately ...
Dec 22, 2022
0
102
Rectal artesunate (RAS), a promising antimalarial drug, proves ineffective at saving the lives of young children suffering from severe malaria, according to the results of a new study conducted by the Swiss Tropical and Public ...
Dec 20, 2022
1
32
Should I get another booster? And if so, which vaccine should be used?
Dec 6, 2022
0
92
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new study published in The Lancet Infectious ...
Nov 29, 2022
0
100
A combined team of researchers from Leibniz Institute for Primate Research and Friedrich-Alexander University of Erlangen-Nürnberg, both in Germany, has found that the SARS-CoV-2 omicron variant BQ.1.1 is resistant to all ...
Offering a booster dose or changing the vaccination schedule available to infants in sub-Saharan Africa could greatly reduce the risk of them contracting potentially fatal diseases such as pneumonia, sepsis and meningitis, ...
Nov 14, 2022
0
51
